Zhili Jin Selected Research

Zhili Jin Research Topics

4	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2023 - 01/2018
2	Inflammation (Inflammations) 01/2023 - 01/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2024
1	Neointima 04/2024
1	Hyperplasia 04/2024
1	Infections 12/2023
1	COVID-19 12/2023
1	Adams-Stokes Syndrome (Stokes-Adams Syndrome) 10/2023
1	Chest Pain (Chest Pains) 10/2023
1	Myocarditis (Carditis) 10/2023
1	Neoplasms (Cancer) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Cardiotoxicity 01/2023
1	Endometriosis 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Epstein-Barr Virus Infections 05/2021
1	Lymphoma (Lymphomas) 05/2021
1	Coinfection 01/2021
1	Critical Illness (Critically Ill) 07/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019

2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2024
1	TNF Receptor-Associated Factor 5IBA 04/2024
1	Factor V (Coagulation Factor V)IBA 04/2024
1	mRNA VaccinesIBA 12/2023
1	sintilimabIBA 10/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	CytokinesIBA 03/2023
1	AMP-Activated Protein KinasesIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 01/2022
1	Dinoprostone (PGE2)FDA Link 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 01/2022
1	Sitagliptin Phosphate (Januvia)FDA Link 01/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Transaminases (Aminotransferases)IBA 01/2021
1	Fibrinogen (Factor I)FDA Link 01/2021
1	ruxolitinibIBA 01/2020
1	Becaplermin (PDGF-BB)FDA Link 01/2019

4	Drug Therapy (Chemotherapy) 10/2023 - 07/2020
1	Injections 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2018